EmitBio

A drug-free treatment for COVID-19

EmitBio fills a critical gap in available treatment options for COVID-19 and other respiratory diseases.

The RD-X19™ light therapy device is an at-home, antiviral treatment in development to speed up recovery, test negative faster, and reduce severity of disease symptoms.

Light-based

The RD-X19 is a drug-free alternative that delivers precise wavelengths of light.

Targeted

The precise light targets the oropharynx to disrupt infection at the source.

Antiviral

Eliminates invading pathogens and stimulates host defense to create an antiviral environment.

Redefining Respiratory Care

We believe there should be a safe, effective, drug-free option in the treatment of respiratory diseases.

EmitBio is committed to finding better treatments for patients and relieve the burden providers have carried in recent years.

Product Pipeline

COVID-19

Preclinical

Human Safety(Phase 1)

Feasibility(Phase 2)

Pivotal(Phase 3)

Commercialized

Mild COVID-19

Long COVID (PCC)

Other Respiratory

Preclinical

Human Safety(Phase 1)

Feasibility(Phase 2)

Pivotal(Phase 3)

Commercialized

RSV

Flu

View More

Earn up to $1,080 in EmitBio’s Clinical Study.

EmitBio Inc. is a life science company developing breakthrough medical devices that change how the world treats respiratory infectious disease.

©2024 EmitBio

Privacy Policy

The EmitBio RD-X19 device is investigational and not currently available for sale